Overview

Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-03-30
Target enrollment:
Participant gender:
Summary
The drug-drug interaction study had been designed to investigate the effect of RAY1225 on the pharmacokinetics of digoxin, Rosuvastatin and
Phase:
PHASE1
Details
Lead Sponsor:
Guangdong Raynovent Biotech Co., Ltd
Treatments:
Atorvastatin
Digoxin
Metformin
Warfarin